01—Abstract
Summary
Summary of the 10-K filed February 21, 2013. Cited figures are marked; the original filing is the authoritative source.
IDEX Corporation's 2012 Form 10-K reports net sales of $1,954,258 thousanda, up 6% from $1,838,451 thousand in 2011, with organic sales up 3%.
Operating income fell 58% to $128,218 thousandb, driven by a $198,519 thousand asset impairment charge recorded in the fourth quarter, largely tied to the IOP (Optics & Photonics) and WST (Water Services & Technology) platforms. Net income decreased 81% to $37,630 thousand, and diluted EPS was $0.45 versus $2.32 in 2011. The effective tax rate rose to 56.3%, mainly due to the nonrecurring impairment charge, which the filing says increased the rate by 26.9%.
By segment, Fluid & Metering Technologies generated 43% of 2012 sales and 82% of operating income, Health & Science Technologies contributed 35% of sales with a negative operating income of $(62,835) thousand, and Fire & Safety/Diversified Products provided 22% of sales and 53% of operating income. Cash flow from operations rose to $326,180 thousandc, and cash and cash equivalents were $318,864 thousand at year end. Total borrowings were $786,576 thousand, and the company stated it was in compliance with its financial covenants, with an interest coverage ratio of 10.05 to 1 and a leverage ratio of 1.92 to 1.
For 2013, management forecast fully diluted EPS of $2.85 to $2.95d. The company repurchased 2.2 million shares for $89.6 million during 2012, and the board increased the repurchase authorization by $200.0 million in October 2012.
02—Key points
Key Highlights
- Net sales of $1.95 billion rose 6%, with organic sales up 3% and acquisitions contributing 5%.
- Operating income fell 58% to $128.2 million, reflecting a $198.5 million non-cash asset impairment charge in Q4 2012.
- Diluted EPS was $0.45, down $1.87 or 81% from $2.32 in 2011; the effective tax rate rose to 56.3%.
- Health & Science Technologies posted an operating loss of $62.8 million due to $170.8 million of impairment charges.
- Cash flow from operating activities increased 50% to $326.2 million, and cash and equivalents totaled $318.9 million.
- Management forecasts 2013 fully diluted EPS of $2.85 to $2.95.
- Total borrowings were $786.6 million, with covenant compliance at an interest coverage ratio of 10.05 to 1 and a leverage ratio of 1.92 to 1.
03—One dollar
Follow one dollar
Of each $1.00 of revenue in FY2012, Idex kept $0.02.
- Revenue$1.95B100.0%
- Cost of revenue−$1.15B58.9%
- Gross profit$803.7M41.1%
- Operating costs−$675.5M34.6%
- Operating income$128.2M6.6%
- Interest, other & tax−$90.6M4.6%
- Net income$37.6M1.9%
Where FY2012 revenue went
$1.95B- Cost of revenue: $1.15B, 59% of revenue
- SG&A: $444.5M, 23% of revenue
- Net income: $37.6M, 1.9% of revenue
- R&D: $36.4M, 1.9% of revenue
- Other operating costs: $194.6M, 10.0% of revenue
- Interest, other & tax: $90.6M, 4.6% of revenue
Kept 1.9% as net incomeNet income $37.6M · 1.9%R&D $36.4M · 1.9%
Full revenue history →04—Financials
Financial Highlights
Figures from 10-KFY2012filed February 21, 2013Financial Statements
FY2012 against FY2011
| Line item | FY2012FY2011 | Change |
|---|---|---|
| Revenue | $1.95B$1.84B | +6.3% |
| Cost of Revenue | $1.15B$1.10B | +4.6% |
| Gross Profit | $803.70M$738.67M | +8.8% |
| R&D Expenses | $36.40M$36.00M | +1.1% |
| SG&A Expenses | $444.49M$421.70M | +5.4% |
| Operating Income | $128.22M$304.66M | −57.9% |
| Interest Expense | $42.25M$29.33M | +44.0% |
| Net Income | $37.63M$193.86M | −80.6% |
| EPS (Basic) | $0.45$2.34 | −80.8% |
| EPS (Diluted) | $0.45$2.32 | −80.6% |
| Shares Outstanding (Basic) | 82.69M82.14M | +0.7% |
| Shares Outstanding (Diluted) | 83.64M83.54M | +0.1% |
05—Questions
Frequently Asked Questions
What caused the sharp decline in 2012 operating income?
The decline was primarily due to $198.5 million of asset impairment charges, mainly within the IOP reporting unit (CVI Melles Griot, Optics & Photonics) and the WST reporting unit (municipal water). Restructuring charges also rose to $32.5 million from $12.3 million.
What is the company's 2013 earnings outlook?
Based on its current outlook, the company forecast fully diluted EPS of $2.85 to $2.95 for 2013.
How strong is the company's balance sheet and debt position?
At December 31, 2012, total borrowings were $786.6 million against shareholders' equity of $1.46 billion. Cash and equivalents were $318.9 million, and $672.5 million of the $700.0 million Revolving Facility was net available. The company stated it was in compliance with its financial covenants.
How is the company returning capital to shareholders?
IDEX declared cash dividends of $0.80 per share in 2012, up from $0.68 in 2011. It repurchased 2.2 million shares for $89.6 million during 2012, and in October 2012 the board increased the repurchase authorization by $200.0 million, leaving $235.4 million available at year end.
How geographically diversified are the company's sales?
In 2012, approximately 51% of total sales were to customers outside the U.S. Net sales were $963.1 million in the U.S., $479.7 million in Europe and $511.4 million in other countries.
06—Continue